SURF stock forecast
Our latest prediction for Surface Oncology, Inc.'s stock price was made on the April 23, 2018 when the stock price was at 12.88$.
In the short term (2weeks), SURF's stock price should outperform the market by 3.76%. During that period the price should oscillate between -2.62% and +3.90%.
In the medium term (3months), SURF's stock price should outperform the market by 7.81%. During that period the price should oscillate between -6.05% and +12.79%.Get email alerts
About Surface Oncology, Inc.
Surface Oncology, Inc. is a clinical-stage immuno-oncology company, which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies. The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.
At the moment the company generates 52M USD in revenues.
On its last earning announcement, the company reported a loss of -0.64$ per share.
The book value per share is 4.42$
Three months stock forecastApril 23, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|